2021-06-28-世界卫生组织-Hypertension_Oman_2020_country_profile_2页_399kb

Oman Hypertension Fact Sheet Summary

Burden of Hypertension (2017)

• Oman's total population in 2017 was 4,665,769, with a hypertension prevalence of 26.2% among adults, affecting approximately 918,000 people.
• Key figures:
  • Awareness (diagnosed): 26.8% of the hypertensive population.
  • Treatment: 7.6% of the overall population was aware and under treatment.
  • Control: Only 7.6% of diagnosed cases had controlled blood pressure.
• Trends show a decrease in uncontrolled hypertension prevalence over time, but challenges remain.

National Systems Response (2019)

• Efforts to reduce salt/sodium consumption and improve availability of essential hypertension medicines (e.g., thiazide diuretics, ACE inhibitors) in healthcare settings.
• Primary health care facilities reported "generally available" resources for these interventions.

National Targets (Up to 2025)

• Aims to reduce hypertension prevalence by 25% (from a 2016 baseline) and cut population salt/sodium intake by 30% to mitigate non-communicable diseases.

WHO Recommendations for Prevention and Control

• Address modifiable risk factors like high salt intake, lack of physical activity, tobacco use, and poor diet.
• Strengthen hypertension cascade: improve diagnosis, treatment, and monitoring; use WHO HEARTS technical packages.
• Track blood pressure control rates and scale up evidence-based interventions.

Key Insights and Data

• Sex and age variations highlight higher burdens in older age groups and males.
• WHO collaboration supports national programs, emphasizing sustainable reduction through policy and health system improvements.
• Despite progress, gaps in control and awareness indicate ongoing needs for enhanced strategies and monitoring.